Skip to main content
Canadian Family Physician logoLink to Canadian Family Physician
letter
. 1996 Mar;42:406, 408, 410.

Equality in health promotion

Jeffrey K Mills
PMCID: PMC2146302  PMID: 8616280

Full text

PDF
406

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Gradman A. H. Hemodynamic effects of the vascular selective calcium antagonist felodipine in patients with impaired left ventricular function. Am Heart J. 1992 Jan;123(1):273–278. doi: 10.1016/0002-8703(92)90791-s. [DOI] [PubMed] [Google Scholar]
  2. Liedholm H., Melander A. A placebo-controlled dose-response study of felodipine extended release in hypertensive patients. J Cardiovasc Pharmacol. 1989 Jul;14(1):109–113. doi: 10.1097/00005344-198907000-00019. [DOI] [PubMed] [Google Scholar]
  3. Lorimer A. R., Pringle S. D. The safety of felodipine. J Cardiovasc Pharmacol. 1990;15 (Suppl 4):S85–S89. doi: 10.1097/00005344-199015004-00026. [DOI] [PubMed] [Google Scholar]
  4. Wiesenberg S. Women on women's health: knowledge, attitudes, and practices. Can Fam Physician. 1996 Jan;42:109–110. [PMC free article] [PubMed] [Google Scholar]

Articles from Canadian Family Physician are provided here courtesy of College of Family Physicians of Canada

RESOURCES